期刊文献+

药物中间体(R)-3-氨基哌啶二(三氟乙酸)盐的合成 被引量:1

Synthesis of( R)-3-aminopiperidine ditrifluoroacetate
下载PDF
导出
摘要 以(R)-2-((苄氧羰基)氨基)-1,5-戊二醇(1)为原料,通过酯化、环合、催化氢化、成盐反应,合成了药物中间体(R)-3-氨基哌啶二(三氟乙酸)盐(5);其结构经1H NMR、13C NMR、IR和元素分析表征。该方法具有成本较低、反应条件温和、易操作等特点,有利于工业化生产。 Drug intermediates of(R)-3-aminopiperdine ditrifluoroacetate was synthesized by using(R)-2-carbobenzoxyamino-1,5-pentanediol as raw materials, through esterification, cyclization, catalytic hydrogenation and salification reaction. And the structure of(R)-3-aminopiperdine ditrifluoroacetate was characterized by 1H NMR, 13C NMR, IR and elemental analysis. The results showed that this method has low cost, mild reaction condition, easy operation and is suitable for production in industrial scale.
出处 《南昌大学学报(工科版)》 CAS 2014年第2期129-132,共4页 Journal of Nanchang University(Engineering & Technology)
关键词 (R)-2-((苄氧羰基)氨基)-1 5-戊二醇 (R)-3-氨基哌啶二(三氟乙酸)盐 合成 盐酸羟胺 ( R ) -2-carbobenzoxyamino-1,5-pentanediol ( R ) -3-aminopiperidine ditrifluoroacetate synthesis hydroxylamine hydrochloride
  • 相关文献

参考文献8

  • 1FENG J, ZHANG Z, WALLACE M B, et al. Discovery of alogliptin: a potent, selective, a bioavailable, and effica- cious inhibitor of dipeptidyl peptidase IV [ J ]. Journal of Medicinal Chemistry ,2007,50(10) :2297 - 2230.
  • 2ECKHARDT M, LONGKOPF E, MARK M, et al. 8-(3- ( R )-Aminopiperidin-l-yl )-7-but-2-ynyl-3-methyl-1-( 4- methyl-quinazolin-2 -ylmethyl ) -3,7-dihydmpurine-2,6 -di- one ( BI 1356), a highly potent, selective, long-acting, and orally bioavailable DPP-d inhibitor for the treatment of type 2 diabetes [ J ]. Journal of Medicinal Chemistry, 2007,50 (26) :6450 - 6453.
  • 3DE COSTA B R, DOMINGUEZ C, HE X S, et al. Synthe- sis and biological evaluation of eonformationally restricted 2- (1-pyrrolidinyl) -N- [ 2- (3,4-dichlorophenyl) ethyl ] -N- methylethylencdiamines as . sigma, reeeptor ligands. 1. pyrrolidine, piperidine, homopiperidine, and tetrahydroiso- quinoline classes [ J ]. Journal of Medicinal Chemistry, 1992,35 (23) :4334 - 4343.
  • 4ISHIKAWA M, HIRAIEA Y, KUBOYA D, et al. Trieyelic pharmacophore-based molecules as novel integrin αvβ3 antagonists. Part Ⅲ: synthesis of potent antagonists with αvβ3/aⅡb133 dual activity and improved water solubility [J]. Bioorganic & Medical Chemistry,2006,14(7) :2131 -2150.
  • 5KAMOCHI Y, KUDO T. The novel reduction of pyridine derivatives with samarium diiodide [ J ]. Heterocycles. 1993,36(10) :2383 - 2396.
  • 6沈大冬,张伯引,刘正俊.N-Boo-3-氨基哌啶及其光学异构体的合成方法:中国,CN101565397A[P].2009-10-09.
  • 7杨登贵,邱小龙,桑大勇,等.光学活性3-氨基吡咯烷、3-氨基哌啶烷及其衍生物的一种通用制备方法:中国,CN101955457A[P].2010-01-02.
  • 8TOMORI H,SHIBUTANI K, OGURA K. Practical synthe- sis of ( s ) -3-( p-Nitrobenzyloxycarbonylamino ) pyrrolidine and its related compounds from L-aspartic acid [ J ]. Het- erocycles, 1997,44 ( 1 ) :213 - 225.

同被引文献3

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部